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Abstract
Background: One of the potential benefits of surgical audit is improved hospital cost-efficiencies arising from
lower resource consumption associated with fewer adverse events. The aim of this study was to estimate the
potential cost-savings for Australian hospitals from improved surgical performance for colorectal surgery attributed
to a surgical self-audit program.
Methods: We used a mathematical decision-model to investigate cost differences in usual practice versus surgical
audit and synthesized published hospital cost data with epidemiological evidence of adverse surgical events in
Australia and New Zealand. A systematic literature review was undertaken to assess post-operative outcomes from
colorectal surgery and effectiveness of surgical audit. Results were subjected to both one-way and probabilistic
sensitivity analyses to address uncertainty in model parameters.
Results: If surgical self-audit facilitated the reduction of adverse surgical events by half those currently reported for
colorectal cancer surgery, the potential cost-savings to hospitals is AU$48,720 (95% CI: $18,080-$89,260) for each
surgeon treating 20 cases per year. A smaller 25% reduction in adverse events produced cost-savings of AU$24,960
per surgeon (95%CI: $1,980-$62,980). Potential hospital savings for all operative colorectal cancer cases was
estimated at AU$30.3 million each year.
Conclusions: Surgical self-audit has the potential to create substantial hospital cost-savings for colorectal cancer
surgery in Australia when considering the widespread incidence of this disease. The study is limited by the current
availability and quality of data estimates abstracted from the published literature. Further evidence on the
effectiveness of self-audit is required to substantiate these findings.
Background
An ‘adverse event’ is defined as the unintentional harm
arising to patients from an episode of health care and
not due to the disease process itself [1]. Adverse post-
operative events are a function of the surgeon’s skill and
judgement, the health care team in which he/she oper-
ates, patient factors such as age and presence of comor-
bidities, elective versus emergency presentations and
hospital systems of care. Common types of adverse sur-
gical events include surgical site infections, anastomotic
leakage, deep vein thrombosis (DVT), respiratory pro-
blems such as pneumonia and pulmonary embolism,
unplanned return to operating theatre, extended hospital
stay, operative and 30-day mortality. Rates of adverse
surgical events may be reduced by various approaches
including using prophylactic antibiotics (for wound
infections) and anticoagulants (for DVT), hospital infec-
tion control programs, and through surgical audits, the
ongoing monitoring of outcomes and training of sur-
geons to improve techniques and judgements.
Surgical audit is a quality improvement process con-
sidered integral to patient care and outcomes and for
the ongoing professional development of surgeons.
Royal Colleges of Surgeons in Australia and the UK are
firmly committed to and strongly endorse the daily
practice of auditing in its various forms within a suppor-
tive, legally protective environment [2]. Ideally, surgical
audit would be implemented with a modern medical
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Optimal practice also requires a closed loop, that is, an
audit is performed, peer review discussion follows, learn-
ing/improved practice initiated and the steps are
repeated continuously. Aside from better patient out-
comes, surgical audit has other potential benefits includ-
ing higher professional satisfaction, enhanced
communication among colleagues and improved hospi-
tal cost-efficiencies arising from lower resource con-
sumption [2]. However, routine use of surgical audit
may not be widespread in Australia [2]. Barriers to
auditing practice have been identified and include the
lack of resources, lack of expertise in design and analy-
sis, staffing communication problems and institutional
impediments [3]. However, recent guidelines for surgical
audit in Australia and New Zealand (NZ) have been
published to help facilitate and standardise practice [1].
Computerized audit systems with dedicated software
offer several advantages for auditing where surgeons or
hospital staff can enter the required data, produce
reports and graphs of outcomes quickly, update their
cumulated cases over time, perform risk-adjusted assess-
ments of outcomes and have the ability to pool case
reports anonymously within surgical units, regions or
nationally [4,5]. In comparison to conducting large sur-
veys or labour-intensive medical chart reviews retrospec-
tively by hospital or research staff, the routine reporting
of audit data electronically is likely to facilitate a cost-
effective auditing approach.
The financial toll to hospitals and health care systems
for adverse surgical events is substantial primarily due
to the attendant high costs incurred for extended hospi-
tal stays [6]. An additional AU $6,826 for each hospital
admission was estimated, on average, in Victoria, Aus-
tralia for in-patients with an adverse event, after adjust-
ing for age and comorbidity [6]. Although many studies
have investigated the costs of wound and other hospital-
acquired infections, these findings are difficult to sum-
marise due to limitations in the way methods were
reported, variations in surgical type, populations, study
designs and health care financing systems [7]. Neverthe-
less, costs per patient with surgical site infections were
estimated to be approximately double those for patients
without infections [7].
The purpose of this study was to estimate the potential
cost-savings relating to improved surgical outcomes for
colorectal surgery attributed to a computerised self-audit
program. We used a modelling approach to synthesize
published hospital cost data with epidemiological evi-
dence of adverse surgical events occurring in Australasia.
Methods
A decision-analytical model was constructed in
TreeAge Pro 2009 software (TreeAge Software Inc,
Williamstown, MA, USA) (Figure 1). Two strategies
were compared in the model; ‘self-audit program’ and
‘usual practice’. The model assumed that after a period
of time following continuous self-audit practice, lower
rates of adverse events would eventuate and incur lower
hospital costs than for usual practice. Therefore, the dif-
ference between the two groups would represent the
expected cost-savings attributed to a self-audit program.
The analytical time-frame was 12 months which was
chosen to capture various caseloads per surgeon.
Several steps were involved in populating the model
parameters and analysis. First, we identified the com-
mon types and frequencies of surgical adverse events
relating to colorectal cancer in Australia and NZ along
with evidence on the effectiveness of surgical audit for
colorectal cancer surgery. A systematic literature review
was undertaken to locate Australian and NZ studies
reporting post-operative outcomes for a series of
patients undergoing surgery for colorectal cancer. Stu-
dies were included if they were published after 2000 (to
reflect current practice), had observational study designs
and involved surgeries for colorectal cancer patients
where post-operative outcomes were reported. PubMed
and Medline databases were used to search for journal
articles in the English language with the following terms
in their title: colorectal, colon, rectal, surgery, surgical or
management combined with adverse events, complica-
tions, post-operative, morbidity, performance, outcomes.
A selection of the most commonly reported adverse
events were included in the model; anastomotic leakage,
wound infection, DVT, respiratory problems (defined as
a collective group including pneumonia, other infec-
tions, pulmonary embolism), re-operation and 30-day
mortality (including operative mortality). Although
‘length of stay’ in hospital was also a common outcome
reported, this is a consequence of arising complications,
it is implicit in the valuation of costs (rather than an
adverse event per se) and therefore was not included as
a separate outcome. Finally, ‘30-day mortality’ was
included in our model as the surgical literature indicates
that a proportion of these are likely to be attributed to
adverse events and omitting them would otherwise
underestimate costs of adverse events.
For evidence relating to the effectiveness of surgical
audit, the following search terms were used: colorectal,
colon, rectal, surgery combined with surgical audit, sur-
gical performance, quality, and appraisal. However, as so
few studies were identified, our criteria was amended to
include studies from any country. Hand-searching article
references and conference abstracts were undertaken to
identify additional studies. The specific search results
are available in Additional file 1.
Second, costs were assigned to each branch of the two
options. This cost-analysis was undertaken from a
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included inpatient costs for colon and rectal surgical
admissions with or without complications. Costs for sur-
gical admissions were derived from the National Hospi-
tal Cost Data Collection 2006-2007 [8] listing
Australian-Refined Diagnostic Related Groups (AR-
DRG) recorded for standard and complicated hospital
episodes. The charge of the self-audit computer software
program and staff cost for data entry by a health
information manager were also considered. Private
patient costs or primary care costs for events occurring
when patients returned into the community were
omitted. Costs were inflated to 2009 Australian dollars
using the health component of the Consumer Price
Index.
Third, the model was calculated by summing the
expected (mean) cost values at each tree node for each
type of adverse event for the ‘self-audit’ and ‘usual
Figure 1 Decision-analytical model of a hypothetical self-audit program and usual practice for surgery for colorectal cancer.
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are based on the probabilities of the adverse events
derived from the literature and their attendant costs. An
expected mean cost for one surgical episode in each
arm was produced. The cost-savings arise from the
reduced level of the ‘surgery plus complications’ DRG
cost estimates in the audit arm compared to the usual
practice arm. However, as the cost of adverse events is
embedded in the DRG estimates and intrinsically linked
to the surgical episode where there is uncertainty in the
exact level of resources consumed, sensitivity analyses
on the DRG cost estimates were performed. One-way
sensitivity analyses on all cost and epidemiological para-
meters were undertaken to investigate the robustness of
the base results to plausible changes in the data esti-
mates (see Table 1 for the range of estimates tested). A
probabilistic sensitivity analysis was also performed, re-
sampling from nominated distributions of data inputs
through 2,000 Monte Carlo simulations. Beta distribu-
tions were assigned to probability estimates (e.g., adverse
event rates, effectiveness rate of surgical audit). Gamma
distributions were assigned to surgery cost variables
because in practice these are normally right-skewed [9]
(e.g., in the case of persistent complications and asso-
ciated long hospital stay). The mean incremental costs
and 95% confidence intervals were extrapolated for dif-
ferent surgical caseloads typically performed by surgeons
in Australia and NZ to obtain the total cost-savings pos-
sible over 12 months. The 95% confidence intervals
reflect the different combinations of plausible adverse
event rates in the literature and variations in cost.
Finally, the results were calculated for all colorectal sur-
geries undertaken in Australia during one year.
Results
Evidence for adverse surgical outcomes
Eleven studies reported adverse surgical outcomes in a
series of patients following surgery for colorectal cancer
(Table 2). The primary goal of all studies was to docu-
ment the surgical management and patient outcomes in
their populations. Two reports documented outcomes
for the same study [10,11]. In summary, the range of
published adverse events used to populate our model
were 0.5-2.8% for anastomotic leaks, 2.1-9.1% for wound
infections, 0.3-6.7% for DVT, 2.7-12.2% for return to
theatre, 0.2-10.7% for respiratory conditions and 0.2-
7.7% for 30-day deaths. The mean of these ranges were
used for the base case scenario with sensitivity analyses
using the low and high values. The rates of adverse
events varied considerably but the difference between
the low and high rates reported were consistently
around 7-9 percentage points. An exception was wound
infection rates of 22.3% for series of 133 patients in Nel-
son, NZ that was more than double those reported
e l s e w h e r ea n dm a yb ee x p l a i n e db yt h er e s e a r c h e r s
including both superficial and deep infections [12]. This
rate was considered an outlier and omitted from our
summary estimates. Five studies, including three in NZ
[12-14], reported outcomes from regional areas
[4,12-15] while the remainder were state-wide [16],
national [10,11,17] or urban-based [18,19]. One study
accounted for pre-operative factors and outcomes were
risk-adjusted [4]. No study reported estimates on multi-
ple complications occurring concurrently during the
hospital stay and only two studies reported mortality
rates directly arising from the complications [11,19].
Post-operative outcomes tended to be poorer for emer-
gency presentations and for rectal surgery, the latter
which involves more complex and difficult surgery
[10,15]. In the National Colorectal Cancer Survey, no
statistically significant differences were found for post-
operative morbidity and mortality for high- and low-
volume surgeons (defined as ≥7o r< 7s u r g e r i e sp e r
quarter, respectively) although some pre-operative prac-
tice differences were evident [11].
Evidence for effectiveness of surgical audit
The evidence-base for ‘audit and feedback’ interven-
tions is very large for clinical studies across a huge
range of medical topics. A Cochrane systematic review
of 118 studies on this topic showed small to moderate
improvements in outcomes overall (median 5%, range
3-11%) [20]. However, studies which evaluated audit
programs for surgery and post-operative outcomes (for
any disease) was scarce. For colorectal cancer surgery,
one Australian study by Bowles 2007 involved a pre-
post study design over four years showing favourable
improvements following the introduction of an audit
program (Table 2) [4]. For example, anastomotic leak
rates decreased from 8.2% to 1.4%, re-operations from
12.2% to 5% and pneumonia from 10.7% to 8.5%.
Audit and regular educational feedback within the
Lothian Surgical Audit program (UK) also produced
notable improvements for colorectal surgery outcomes;
anastomotic leakage from 5% to 2% and stoma rates
following rectal cancer surgery from 28% to 12%
[21,22]. In a second Australian study involving surgery
for all diseases, Kable et al. (2002) discuss the ‘degree
of preventability’ of adverse surgical events [17]. A
proportion of complications have low preventability
(31.4%) while others were highly preventable (47.6%).
As such, the authors highlight that it is not possible to
f u l l ye l i m i n a t ea l la d v e r s ee v e n t sa s2 1 %w e r en o tc o n -
sidered preventable [17]. In the Scottish Audit of Sur-
gical Mortality, significant improvements in most
adverse factors occurred over 9 years (1994-2002) after
audit and peer review by surgical assessors [23]. These
included failure to use DVT prophylaxis reducing from
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reduced from 8.2% to 6%, failure to use high-depen-
dency or intensive care units reduced from 18.4% to
5.4% [23]. Finally, support for computerized surgical
audit for colorectal cancer is advocated [5,24] although
formal evaluation of their effectiveness have not been
reported.
Results of model
The data used to populate the model included estimates
reported in the published literature however a number
of assumptions were also necessary (Table 1). The
expected mean costs of surgical treatment for a single
case of colorectal cancer, under usual practice was
$20,627 compared to that for a self-audit program
$18,156 if the self-audit program reduced common
adverse events by half. A cost-saving of $2,471 per case
was predicted. Sensitivity analysis showed that changes
to this expected mean cost of $18,156 was most sensi-
tive to variation of ± 30% in the cost of uncomplicated
colon surgery (range $15,652-$20,661) and rectal surgery
(range from $16,711-$19,602) (Figure 2).
Expected mean costs for the two options are more
precise from a probability sensitivity analysis (Table 3).
For each surgical patient, results from the probabilistic
sensitivity analysis produced mean cost savings of
$2,436 for a 50% reduction in adverse events, $1,248 for
a 25% reduction and $3,636 for a 75% reduction (Table
Table 1 Data parameters used in calculations, plausible ranges, sources and assumptions
Description Estimate
(plausible range)
Source
Surgical cases per year (for one surgeon) Scenario 1: 20
1 [11](<7, ≥7, over 15 per 3 months)
Scenario 2: 40
Scenario 3: 70
% reduction in adverse event rates Scenario 1: 50%
(base effect)
[4,17,22-24,30,31]
Scenario 2: 25%
(small effect)
Scenario 3: 75%
(large effect)
% of colon and rectal surgery cases
Colon 68.7-75.9% [11]
Rectal 24.1-31.3%
Baseline adverse event rates
2,3
Anastomotic leak 4.4% (0.5-8.2) Mean of low/high values from up to 11
studies [4,10-19,22] (see Table 2)
Wound infection 5.6% (2.1-9.1%)
DVT 3.5% (0.3-6.7%)
Respiratory complications (pulmonary embolism, infection, pneumonia) 5.5% (0.2-10.7%)
Return to operating theatre 7.5% (2.7-12.2%)
Post-op deaths (<30 days) % 3.3% (0.2-6.4%) As above
(% attributed to complications) (16%) [11]
Hospital costs (AUD 2009): AR-DRGs code (ALOS):
Rectal resection with complications $33,277 G01A (18.4 days)
Rectal resection with no complications $18,094 G01B (9.8 days)
Colon procedures with complications $30,899 G02A (17.8 days)
Colon procedures with no complications $14,283 G02B (8.2 days)
12-month subscription to ‘surgical performance’ self-audit software
4 $250 http://www.surgicalperformance.com US$200
Data entry of surgical outcomes into audit software
5 - performed by health
information manager, 20 minutes per audit
$16.67 per audit Based on salary $50 per hour
Abbreviations: ALOS - average length of stay, DVT - deep vein thrombosis, AR-DRG - Australian Refined Diagnostic Related Group
1. Scenario 1 would apply to the majority of surgeons in Australia and New Zealand [11].
2. Implicit in the plausible range of complication rates listed above are the variations reflected in the usual population of cases requiring colon or rectal surgery,
i.e., a mix of emergency and elective cases, colon and rectal cases, age, Dukes stage and presence of comorbidity.
3. As there is no evidence on extent of type of multiple complications occurring concurrently with colorectal surgery patients, the estimates assume mutually
exclusive complication rates. An exception is ‘30-day mortality’ where the percentage of 30-day deaths attributed to complications is 16% and costs were
adjusted down to avoid double-counting.
4. Self-audit process involves feedback with peers - any attendant costs here were not included. It is assumed peer discussions would be periodically scheduled
in normal practice.
5. Data entry is assumed to incur the time of a health info manager.
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Author, Year & No.
cases
% elective
cases
% anastomotic
leak (AL)
% wound
infection
%
DVT
% return to
theatre
% respiratory % 30-day
deaths
Semmens 2000 [16] n =
9,673
77% 6.5% 8.3% post-op
infect
ns Most of AL
(est.5%)
ns 4.2%
Birks 2001 [15]
n = 877
69% 3.3% 7.2% ns 5.7% ns 4.1% CRC
patients
Kable 2002 [17]
n = 5,432
ns ns 2.1% 0.3% ns pneumonia 0.2% 0.8%
Killingback 2002 [19] n
= 1,418
100% 4.1% 2.1% 1.1% 2.7% 6.7% (incl various) 1.6%
McGrath 2004 [10,11] &
2005
n = 1,911
86-93% 0.0-3.0% 6.6-9.1% 1.0-
6.7%
ns 0-1.6% pulmonary
embolism
4.0-4.3%
Wong 2005 [30]
n = 1,293
83% 0.5-1.1% 4.2-7.8% 2.3-
3.9%
2.7-6.7% ns 1.2-7.7%
Gollop 2006 [13]
n = 170
71% 3% Ns ns 12% ns 5%
Samson 2007 [14]
n = 191
ns 4.5% 11% ns 7% ns 4%
O’Grady 2007 [12]
n = 133
91% 4.7% 22% ns 3% 7.5% 0.8%
Bowles 2007 [4]
n = 500 pre
n = 100 post
63% Pre 8.2%
Post 1.4%
Ns ns Pre 12.2%
Post 5%
ns Pre 6.38%
Post 0%
Frye 2009 [18]
n = 1,513
100% 3.8% Ns ns ns ns 0.2%
SUMMARY
1
low-high values
0.5-8.2% 2.1-9.1% 0.3-
6.7%
2.7-12.2% 0.2-10.7% 0.2-7.7%
(Abbreviations: ns = not stated, DVT = deep vein thrombosis, AL = anastomotic leak, CRC = colorectal cancer)
1. Summary rates exclude 0% where reported and 22.3% wound infection rate from O’Grady 2007 that was considered an outlier and possibly due to inclusion
of superficial and deep infections.
Figure 2 Results of the one-way sensitivity analyses.
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extrapolated to annual caseloads of 20, 40 or 70 to esti-
mate annual cost-savings for one surgeon (Table 3). For
the most typical caseload of around 20 surgeries per
year for one surgeon [11], average cost-savings were
estimated at $48,720 (95%CI: $18,080-$89,260). The
annual incidence of colorectal cancer in Australia 2005
was 13,076 cases. Assuming 95% of all cases have sur-
gery and calculating the potential cost-savings of $2,436
for each person (on average) if adverse event rates are
halved, it is estimated that Australian hospitals could
save $30.3 million dollars per year.
Discussion
We used a mathematical model to synthesize the pub-
lished evidence on the extent of surgical adverse events
and attendant costs for colorectal cancer surgery in Aus-
tralia. The advantage of this type of model is that it
explicitly identifies the options and parameters under
consideration and allows for detailed sensitivity and sce-
nario (what-if) analyses. Our findings showed that if
self-audit facilitated the reduction of adverse surgical
events by half those currently reported for colorectal
cancer surgery, the potential annual hospital cost-sav-
ings was $48,000 for each surgeon treating 20 cases per
year and could range from $18,000 to $90,000. The
wide range of potential cost-savings reflects the com-
bined uncertainty of published estimates on adverse
events rates, different surgical casemix and the potential
variation in the accompanying costs. The potential cost-
savings is substantial when considering the widespread
incidence of this disease and the cost containment goals
in all hospitals.
The study is limited by the current availability and
quality of data estimates abstracted from the published
literature. The 11 studies providing estimates on adverse
event rates were inconsistent in the use of standard defi-
nitions and methods used to measure the various types
o fa d v e r s ee v e n t s .T h i sa p p e a r st ob eac o m m o np r o -
blem internationally as confirmed in a large UK review
on the topic of monitoring adverse events [25]. The cur-
rent Australian and NZ guidelines for surgical audit
may alleviate these problems [1]. Furthermore, each
study used a different set of outcomes, despite assessing
the same disease (colorectal cancer), and few have
adjusted for baseline (pre-operative) risk characteristics
(e.g., age, comorbidities, body mass index). In addition,
it is evident that differences exist in the case mix of
patients in the studies, with some studies having a
higher proportion of emergency presentations [4,13,15].
Despite this, the adverse event rates did not always
appear higher than for the group of studies overall, as
m a yh a v eb e e ne x p e c t e d .N e v e r t h e l e s s ,c o m p a r i s o n s
across studies are problematic. It has also been stated
that studies involving surveys of surgeons with self-
reported data or retrospective medical chart reviews are
likely to underestimate the true prevalence of adverse
events and may be unreliable [11].
The lack of evidence on the effectiveness level of audit
programs for surgery is also a limitation of the study.
This is probably because of, in part, the confronting nat-
ure of the topic, the possible legal and social ramifica-
tions, time pressures and overall reluctance of doctors
to be involved in this kind of study. As assumptions
were made about this effect size, the findings should be
considered as exploratory. Furthermore, the effectiveness
level of surgical audit is governed, in part, by the initial
adverse event rates with greater improvements possible
when rates are relatively high to begin with [4,23]. How-
ever, our findings are based on the best available evi-
dence and provide an indication of the level of cost-
savings possible. A more robust analysis would require
Table 3 Potential annual cost-savings for reduced adverse events for colorectal cancer surgery by surgical caseload
(AU$ 2009)
% reduction in adverse events No. cases Mean cost-saving
$
(95% CI)
$
50% (baseline) 1 2,436 904 - 4,463
20 48,720 18,080 - 89,260
40 97,440 36,160 - 178,520
70 170,520 63,280 - 312,410
25% (small effect) 1 1,248 99 - 3,149
20 24,960 1,980 - 62,980
40 49,920 3,960 - 125,960
70 87,360 6,930 - 220,430
75% (large effect) 1 3,636 1,580 - 6,047
20 72,720 31,600 - 120,940
40 145,440 63,200 - 241,880
70 254,520 110,600 - 423,290
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trial that evaluates the potential health benefits and pre-
cise cost-savings of self-audit benefits in comparison
with usual practice. It would be important for surgical
outcomes to be risk-adjusted [26] using a validated sys-
tem like CUSUM [4]. However, such a trial may be
unethical and not particularly policy-changing since The
Royal Australian College of Surgeons already encourages
systematic auditing practice[1].
The analysis also relied on an aggregated national
costing report on episodes of colorectal surgery in Aus-
tralian hospitals [8]. While there are studies reporting
costs of hospital-acquired surgical site infections [27,28],
for consistency across the other outcome types, a gen-
eric AR-DRG cost (with complications) was assigned. A
more detailed micro-costing approach may have pro-
vided precise estimates for each complication type but is
very resource-intensive and uncommon [29]. Further-
more, micro-costing may have produced higher costs
per person with an adverse event, as previously found
for surgical site infections [28], and would imply that
our average cost-savings may be underestimated, but
conservative. Furthermore, our costs are likely to a frac-
tion of all health care costs because we have excluded
any costs flowing on to primary care and community
health providers. For example, several studies have con-
firmed that more than 50% of surgical site infections
occurred post-discharge creating substantial and more
hidden costs eventually borne by primary care providers
[27,28].
Conclusions
Using best-available evidence on the outcomes of col-
orectal cancer surgery in Australia and NZ and explor-
ing the cost-savings accompanying lower hospital
resource consumption from improvements in surgical
performance, we found substantial economic dividends
accruing for hospitals. A computerised self-audit pro-
gram operating with frequent data input is a low-cost
tool to facilitate potential improvements in surgical
performance.
Additional file 1: Review studies reporting on adverse surgical
outcomes following surgery for colorectal cancer. Tabulated results
of the systematic review on studies reporting on adverse surgical
outcomes following surgery for colorectal cancer.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2482-10-4-
S1.DOCX]
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